Together, these results demonstrated that LAE inhibits the cell migration of ER− breast cancer cells likely via suppressing the phosphorylation of TGF-β1/Erk1/2 as well as TGF-β1/SMAD3 signals. The gene discussed is MAPK3; the disease is breast carcinoma.